Forest anti-infective hits main goal in studies
NEW YORK, June 19 |
NEW YORK, June 19 (Reuters) - Forest Laboratories Inc (FRX.N) said on Thursday its experimental anti-infective drug proved not inferior to a combination of two older medicines, reaching the main goal in two late-stage trials.
Forest said it was "extremely pleased" with the positive results for ceftaroline. (Reporting by Lewis Krauskopf, editing by Gerald E. McCormick)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters